Evidence map›Paper›PMID 38248717›Full record

ArticleMedicines (Basel, Switzerland)2024

Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships.

Swagatika Das, Praveen K Roayapalley, Hiroshi Sakagami, Naoki Umemura, Dennis K J Gorecki, Mohammad Hossain, Masami Kawase, Umashankar Das, Jonathan R Dimmock

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicines (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Swagatika DasDrug Discovery and Development Research Cluster, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Praveen K RoayapalleyDrug Discovery and Development Research Cluster, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.ORCID 0000-0003-3712-5790
Hiroshi SakagamiMeikai University Research Institute of Odontology, Saitama 350-0283, Japan.ORCID 0000-0001-8001-2121
Naoki UmemuraDepartment of Oral Biochemistry, Asahi University School of Dentistry, Gifu 501-0296, Japan.ORCID 0000-0002-3249-782X
Dennis K J GoreckiDrug Discovery and Development Research Cluster, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Mohammad HossainSchool of Sciences, Indiana University Kokomo, Kokomo, IN 46904-9003, USA.ORCID 0000-0002-9953-586X
Masami KawaseFaculty of Pharmaceutical Sciences, Matsuyama University, Matsuyama 790-8578, Japan.ORCID 0000-0001-5592-2553
Umashankar DasDrug Discovery and Development Research Cluster, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Jonathan R DimmockDrug Discovery and Development Research Cluster, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
University of Saskatchewan · CAAsahi University · JPIndiana University Kokomo · USMatsuyama University · JPMeikai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cytotoxicitymodes of actionQSARselective toxicityunsaturated ketones

Identifiers

PMID38248717
PMCPMC10821124
OpenAlexW4390749181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.